Could minimally invasive surgery be right for me?
Minimally invasive surgery (MIS) refers to laparoscopic surgery and robotic surgery. These two types of surgery are different based on the tools used during the procedure. The surgeon will either use robotics or laparoscope tools. Surgeons will usually recommend a laparoscopic or robotic procedure based on their own experience and preference.
Minimally invasive surgeries are much more common now because this type of surgery can offer colorectal cancer patients a less painful way to remove part of the colon or the entire colon, create an ostomy, or reconnect and reconstruct the colon.
Minimally invasive surgery can also be used, in some cases, to remove rectal tumors.
Many studies have shown that these surgeries are just as safe as open surgery but they make recovery faster and easier.
Most patients can undergo minimally invasive surgery, such as those with:
- Early stage cancer
- Less advanced cancer
- No prior major surgeries
- Fewer radiation treatments
- Lower Body Mass Index (BMI)
Open surgery might still be recommended for patients with:
- Spread of cancer
- Metastases (additional growths)
- Need to remove the tumor completely
- History of medical conditions
- Higher Body Mass Index (BMI) or obesity
Talk to your doctor to find out if minimally invasive surgery is an option for you.
Top resources
Where breakthroughs begin: Project Cure CRC spotlight on Dr. Lisa Mielke
hrough Project Cure CRC, the Alliance is fueling bold, early-stage research with the potential to transform colorectal cancer treatment. Dr. Lisa Mielke’s groundbreaking work explores how the gut’s immune system and nerve signaling influence cancer growth—opening the door to new therapeutic approaches, including repurposed existing drugs. This is what’s possible when promising ideas get the support they need to move forward.
John E.: Biomarker testing uncovered a pivotal treatment option
After a grim prognosis, biomarker testing revealed a targeted treatment option for John E. Learn how knowing your biomarkers can change what’s possible.
"Clinical trials gave us time": A daughter’s tribute to her mother’s courage
When Kate Shin’s mother faced rectal cancer, clinical trials gave them precious time together. Now, Kate shares her story to encourage access to screening and innovative care, including clinical trials.